Open-access publisher Frontiers has announced a major milestone - the publication of its 150,000th open-access article. This is a major achievement – not just for Frontiers – but for all its authors as they together seek to fulfill the overarching goal to make science open – accelerating scientific and technological innovation, societal progress, and economic growth.
Frontiers’ 150,000th paper, COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2, has been published in Frontiers in Cardiovascular Medicine. The article reviews the management of arrhythmic risk in the use of a combination of multiple drugs in COVID-19 patients, an important resource for clinicians. It is authored by a team of specialists from the School of Physiology, Pharmacology and Neuroscience at the University of Bristol, as well as the Liverpool Heart and Chest Hospital and the Gloucestershire Hospitals NHS foundation trusts.
The timing of the article is pertinent: Frontiers need high-quality research around COVID-19 with a sense of great urgency. The scientific community is rallying to respond and find a way to manage – and eventually bring a halt to – the spread of the virus. While several journals and publishers have exceptionally made some of their articles free to access and read during this time of crisis, the open and free access to research is the norm at Frontiers.
The paper will also be published via Frontiers’ Coronavirus Knowledge Hub, a platform launched as a trusted source of the latest science and expert opinion on SARS-CoV-2 and COVID-19.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
Click here to read the original press release.
